Status:

COMPLETED

Efficacy of Bifidobacterium Longum 35624 on the Quality of Life of IBS Patients With Different Symptom Severity

Lead Sponsor:

Biocodex

Conditions:

Irritable Bowel Syndrome

Eligibility:

All Genders

18+ years

Brief Summary

The main objective of this observatory is to evaluate the effect of Bifidobacterium longum 35624 on the quality of life of IBS patients having different subtypes of transit pattern and different level...

Detailed Description

This observatory evaluate the effect of Bifidobacterium longum 35624 on the quality of life of IBS patients having different subtypes of transit pattern and different level of symptom severity, after ...

Eligibility Criteria

Inclusion

  • Male or female, at least 18 years of age
  • Gastroenterology consultation for an Irritable Bowel Syndrome according to Rome IV criteria
  • Having received a first prescription of Bifidobacterium longum 35624 during the consultation (independently of participation in the observatory)
  • Informed and having declared his/her non-opposition to the study.

Exclusion

  • Not having a good enough command of reading and comprehension of the French language to correctly complete the questionnaires and the notebook
  • Having already taken Bifidobacterium longum 35624
  • Having received probiotics or antibiotics within 2 weeks previous
  • Having started within the last 7 days a treatment that can interfere with the investigator's evaluation of the investigational product under investigation
  • Participant in another trial
  • Pregnant or breastfeeding women
  • Being under guardianship or curator.
  • Not having a good enough command of reading and comprehension of the French language to correctly complete the questionnaires and the notebook

Key Trial Info

Start Date :

November 22 2018

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

June 26 2020

Estimated Enrollment :

220 Patients enrolled

Trial Details

Trial ID

NCT04662502

Start Date

November 22 2018

End Date

June 26 2020

Last Update

March 12 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hôpital Avicenne

Bobigny, France, 93009

Efficacy of Bifidobacterium Longum 35624 on the Quality of Life of IBS Patients With Different Symptom Severity | DecenTrialz